{
  "id": 6253053,
  "title": "Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil",
  "url": "https://urgent.news/2026/09/08/biocon-shares-rise-2-on-10-year-pertuzumab-supply-deal-for-breast",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T05:48:22.000Z",
  "source": {
    "name": "The Economic Times - Top News",
    "slug": "the-economic-times-top-news",
    "url": "https://economictimes.indiatimes.com/markets/stocks/news/biocon-shares-rise-2-on-10-year-pertuzumab-supply-deal-for-breast-cancer-therapy-in-brazil/articleshow/133910110.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the country’s PDP programme, providing access to around 70% of public-sector demand.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}